Find your path to Mary
Chief Financial Officer at Cullinan Therapeutics
Intro paths
→
In turn, Mary can intro founders to Cullinan Therapeutics's investors below.
Cullinan Therapeutics's investors · 4
Experience
- Cullinan TherapeuticsChief Financial Officercurrent2024 — presentCambridge, Massachusetts, United States
- Talaris TherapeuticsPresident and Interim Chief Executive Officer2023
- Talaris TherapeuticsChief Financial Officer2021 — 2023Boston
- OncorusBoard Director, Audit Committee Chair2020 — 2023
- Vertex PharmaceuticalsVice President, Strategic Operations, Vertex Cell & Genetic Therapies (VCGT)2020 — 2021
- Semma TherapeuticsChief Financial Officer/Chief Operating Officer2019 — 2020Cambridge, MA
- CBIABoard Director, Exec Committee, Board Chair2011 — 2019
- Achillion Pharmaceuticals, Inc.EVP & Chief Financial Officer2000 — 2018New Haven
- PricewaterhouseCoopersSenior Manager, TICE1991 — 2000Connecticut, state-wide
- Congress for a Working AmericaCommunity Organizer and Financial Manager1986 — 1989Greater Milwaukee
Skills & more
Biotechnology6Strategic Planning6Investor Relations2Strategy8Venture Capital8Corporate Development9Mergers & Acquisitions6Due Diligence6Pharmaceutical Industry7Financial Modeling5Start-ups1Lifesciences2
+8 more
Financial AnalysisClinical DevelopmentSEC filingsPrivate EquityLife SciencesBusiness StrategyManagementIPO- Certified Public Accountant — State Board of Accountancy
From Mary's professional profile.
Frequently asked questions
- Who is Mary Kay Fenton?
- Chief Financial Officer at Cullinan Therapeutics
- Where does Mary Kay Fenton work?
- Mary Kay Fenton is Chief Financial Officer at Cullinan Therapeutics.
- Where did Mary Kay Fenton go to school?
- Mary Kay Fenton studied at College of the Holy Cross (A.B., Economics); The George Washington University (BIO Boardroom Ready Program); University of Connecticut School of Business (M.B.A., Finance).
Same school
Also attended College of the Holy Cross81
Nick WashburnSenior Managing Director, Intel Capital (North America)Sarah KimballInvestor at Spark CapitalLiz FoxProduct Marketing and Communications at In-Q-TelGabrielle BrigantiCommunications Associate at Deerfield Management CompanyJohn DelfinoPartner, General Counsel at TCVAdriana RocheHead of Talent at Uncork Capital
+ 75 more
Also attended The George Washington University382
RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauZach CollinsPartner at Mission Biocapital
+ 376 more
Also attended University of Connecticut School of Business41
Brian CoburnPrincipal at Eos Venture Partners LimitedGregor KevrekianPartner at Healthier CapitalSabine QuetantMarketing at Collide CapitalJustin AguadoSenior Associate at CVS Health VenturesChris HillockVP, Portfolio Development at Dell Technologies CapitalPreston NoonPartner, Co-Founder at Agent Capital
+ 35 more
Shared employers
Also worked at Cullinan Therapeutics6
Kristen LaguerreExecutive Partner at MPM BioImpactTony RosenbergManaging Director at MPM BioImpactMittie DoyleChief Medical Officer at Avalo TherapeuticsDavid MeekChief Executive Officer at Bluebird BioJennifer MichaelsonChief Scientific Officer at Cullinan TherapeuticsNadim AhmedPresident and Chief Executive Officer at Cullinan Therapeutics
Also worked at Talaris Therapeutics3
Also worked at Vertex Pharmaceuticals60
Bruce SachsInvestor at CRV (Charles River Ventures)Jesper GromadaInvestor at Third Rock VenturesStephen ChambersGeneral Partner at SOSVAlexandra CantleyManaging Partner at Polaris PartnersRoger TungVenture Partner at Longwood FundLloyd CarneyStrategic Advisor at Vertical Venture Partners
+ 54 more
